미국의 부인과용 의자 및 테이블 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 용도별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

U.S. Gynecological Chairs And Tables Market Growth & Trends:

The U.S. gynecological chairs and tables market is anticipated to reach USD 283.8 million by 2030 and is anticipated to expand at a CAGR of 6.5% during the forecast period, according to a new report by Grand View Research, Inc. The expansion of the U.S. gynecological chairs and tables industry is largely attributed to the growing adoption of minimally invasive surgical (MIS) techniques in gynecology, which requires specialized equipment to enhance procedural efficiency and patient comfort. MIS procedures have gained significant popularity in the U.S. due to their advantages over traditional open surgeries, such as reduced postoperative pain, shorter hospital stays, and quicker recovery times. In gynecology, procedures like laparoscopic hysterectomies and myomectomies are increasingly performed using MIS techniques, driven by technological advancements and a heightened focus on patient-centered care.

The Society for Women's Health Research reports that approximately 26 million women in the U.S., aged 15 to 50, are affected by uterine fibroids, leading to a substantial demand for laparoscopic procedures. Additionally, a study published in the International Journal of Women's Health indicates that the prevalence of uterine fibroid disease varies between 5.4% and 23.6%, depending on the age group. Furthermore, the Office on Women's Health notes that fibroids develop in approximately 20% to 80% of women by the age of 50. This substantial patient population has led to an increased demand for laparoscopic procedures.

The rising preference for MIS in gynecology directly impacts the need for specialized chairs and tables designed to accommodate these advanced procedures. These equipment pieces are engineered to provide optimal patient positioning, facilitate surgeon access, and integrate seamlessly with imaging and robotic systems. As MIS becomes more prevalent, healthcare facilities are investing in state-of-the-art gynecological chairs and tables to enhance procedural outcomes and patient safety.

U.S. Gynecological Chairs And Tables Market Report Highlights:

• Based on product, gynecological chairs dominated the U.S. market share, while the gynecological tables segment is projected to expand at a steady CAGR. This growth is fueled by high procedure volumes in OB/GYN facilities and a rising emphasis on women's health and routine pelvic examinations.
• Based on application the pelvic surgery segment held a notable share of the market, while the urology surgery segment is projected to grow at the fastest CAGR of 8.1%, driven by rising urological procedures and technological advancements.
• Based on end use, the office-based surgery (OBS) segment contributed notably to market revenue. The Department of Veterans Affairs (VA) segment is projected to experience the fastest growth rate. This reflects rising investments in VA facilities and increased surgical procedure volumes.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Region
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Gynecological Chairs and Tables Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of U.S. Gynecological disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Growing awareness of U.S. Gynecological disorders and treatments
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of products and U.S. Gynecological treatments
• 3.3. U.S. Gynecological Chairs and Tables Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. U.S. Gynecological Chairs and Tables Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Gynecological Chairs and Tables Market: Product Movement Analysis
• 4.3. U.S. Gynecological Chairs and Tables Market by Product Outlook (Volume, Units; Revenue, USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. U.S. Gynecological Chairs
  • 4.5.1. U.S. Gynecological Chairs Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.5.1.1. Electric
      • 4.5.1.1.1. Electric Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.5.1.2. Manual
      • 4.5.1.2.1. Manual Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 4.6. U.S. Gynecological Tables
  • 4.6.1. U.S. Gynecological Tables Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.6.1.1. Powered
      • 4.6.1.1.1. Powered Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.6.1.2. Non-powered
      • 4.6.1.2.1. Non-powered Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 4.7. Operating Table Boot Stirrups
  • 4.7.1. Operating Table Boot Stirrups Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)

Chapter 5. U.S. Gynecological Chairs and Tables Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Gynecological Chairs and Tables Market: Application Movement Analysis
• 5.3. U.S. Gynecological Chairs and Tables Market by Application Outlook (Revenue, USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Urology Surgery
  • 5.5.1. Urology Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.6. Pelvic Surgery
  • 5.6.1. Pelvic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. U.S. Gynecological Chairs and Tables Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Gynecological Chairs and Tables Market: End Use Movement Analysis
• 6.3. U.S. Gynecological Chairs and Tables Market by End Use Outlook (Revenue, USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Department of Veterans Affairs (VA)
  • 6.5.1. Department of Veterans Affairs (VA) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.6. Office-Based Surgery (OBS)
  • 6.6.1. Office-Based Surgery (OBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Gynecological Chairs and Tables Market: Region Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Gynecological Chairs and Tables Market: Region Movement Analysis
• 7.3. U.S. Gynecological Chairs and Tables Market by Region Outlook (Volume, Units; Revenue, USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. California
  • 7.5.1. California Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Texas
  • 7.6.1. Texas Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. Florida
  • 7.7.1. Florida Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.8. New York
  • 7.8.1. New York Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.9. Pennsylvania
  • 7.9.1. Pennsylvania Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.10. Illinois
  • 7.10.1. Illinois Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.11. Ohio
  • 7.11.1. Ohio Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.12. Georgia
  • 7.12.1. Georgia Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.13. North Carolina
  • 7.13.1. North Carolina Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.14. Michigan
  • 7.14.1. Michigan Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. STERIS
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. The Brewer Company, LLC
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Midmark Corporation. (Ritter Midmark)
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Clinton Industries, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. UMF Medical
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Hausmann Enterprises, LLC
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Baxter (Hill-Rom Holdings)
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Bailey's Medical Supplies
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Stryker
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Getinge AB
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Siemens Medical Solutions
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives